Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Combining L-Methylfolate With Antidepressant Shows Significant Boost In Patient Response
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Combining L-Methylfolate With Antidepressant Shows Significant Boost In Patient Response
Admin Tue Jun 14, 2011 9:27 am
Combining L-Methylfolate With Antidepressant Shows Significant Boost In Patient Response
New findings from a multi-center, randomized, placebo-controlled clinical study of Deplin® 15mg (L-methylfolate) added to commonly prescribed antidepressants known as selective serotonin reuptake inhibitors (SSRIs) showed that all patients who achieved remission at 30 days using Deplin® 15mg adjuvant therapy, and who chose to enter a 12 month maintenance phase, maintained their remission after a year of treatment.
"In patients with inadequate response to SSRI monotherapy for depression, the addition of L-methylfolate 15mg (Deplin®) may offer a personalized approach to improve responses to antidepressant therapy in genetic errors of folate metabolism such as the MTHFR polymorphism," said Dr Zajecka. "Although this study is speculative, it represents promise in a genotypically defined subgroup of patients and an option for personalized medicine in major depression."
Click here for more details about this study: Deplin + SSRI
New findings from a multi-center, randomized, placebo-controlled clinical study of Deplin® 15mg (L-methylfolate) added to commonly prescribed antidepressants known as selective serotonin reuptake inhibitors (SSRIs) showed that all patients who achieved remission at 30 days using Deplin® 15mg adjuvant therapy, and who chose to enter a 12 month maintenance phase, maintained their remission after a year of treatment.
"In patients with inadequate response to SSRI monotherapy for depression, the addition of L-methylfolate 15mg (Deplin®) may offer a personalized approach to improve responses to antidepressant therapy in genetic errors of folate metabolism such as the MTHFR polymorphism," said Dr Zajecka. "Although this study is speculative, it represents promise in a genotypically defined subgroup of patients and an option for personalized medicine in major depression."
Click here for more details about this study: Deplin + SSRI
Admin- Admin
- Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia -
Similar topics» Which Combination of "Predictor of Response" & "Psychotherapeutic Approach" will result in Good Response?.
» L-Methylfolate: Who Will benefit
» Etravirine Shows Fewer Neuropsychiatric AEs Than Efavirenz
» Combining Vitamin D to Fluoxetine for Major Depressive Disorder
» Combining Risperidone and SSRIs (Benefit Vs Side Effects)
» L-Methylfolate: Who Will benefit
» Etravirine Shows Fewer Neuropsychiatric AEs Than Efavirenz
» Combining Vitamin D to Fluoxetine for Major Depressive Disorder
» Combining Risperidone and SSRIs (Benefit Vs Side Effects)
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
» L-Methylfolate: Who Will benefit
» Vitamins & Supplements in Clinical Practice.
» Imaging Biomarkers for Outcomes in Mild TBI
» Q.5 Clozapine Neutopenia
» Treating Disorders!
» Cortical Abnormalities in Adults & Adolescents with MDD
» Efficacy of Antipsychotics in Pediatric Acute Mania
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?